<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Combination therapy strategies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/combination-therapy-strategies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 21:07:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Combination therapy strategies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Unraveling Epigenetic Control of T Cell Exhaustion in Cancer</title>
		<link>https://bioengineer.org/unraveling-epigenetic-control-of-t-cell-exhaustion-in-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 21:06:48 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[Cancer immunotherapy advancements]]></category>
		<category><![CDATA[Combination therapies** **Açıklama:** 1. **T cell exhaustion:** Makalenin ana konusu ve temel araştırma alanı. 2. **Epigenetic regulation:** Makalenin özellikle vurguladığı]]></category>
		<category><![CDATA[Combination therapy strategies]]></category>
		<category><![CDATA[epigenetic regulation]]></category>
		<category><![CDATA[Epigenetic regulation of T cells]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **T cell exhaustion]]></category>
		<category><![CDATA[T hücre tükenmesini]]></category>
		<category><![CDATA[T-cell exhaustion mechanisms]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[tumor microenvironment immunosuppression]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unraveling-epigenetic-control-of-t-cell-exhaustion-in-cancer/</guid>

					<description><![CDATA[Recent advancements in cancer treatment have highlighted the remarkable potential of T cell-based immunotherapy strategies, which include immune checkpoint blockade (ICB) and chimeric antigen receptor (CAR) T cells. These innovative approaches have undoubtedly transformed the landscape of cancer care, offering new avenues for treatment. Despite their success in numerous cases, there remains a significant proportion [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319150</post-id>	</item>
	</channel>
</rss>
